Clinical trial
A Multicenter, Open-label Study to Determine the Pharmacokinetics, Safety, and Outcomes of Imipenem/Cilastatin/Relebactam During Treatment of Acute Pulmonary Exacerbations in Adolescent and Adult Patients With Cystic Fibrosis
NCT05561764 is registered in ClinicalTrials.gov with Hartford Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-label Study to Determine the Pharmacokinetics, Safety, and Outcomes of Imipenem/Cilastatin/Relebactam During Treatment of Acute Pulmonary Exacerbations in Adolescent and Adult Patients With Cystic Fibrosis
- Lead sponsor
- Hartford Hospital
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 3, 2023
- Completion date
- December 11, 2024
- Enrollment
- 4 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.